GSTP1 and prostate carcinoma: Considering that the discrimination power of serum prostate-specific antigen (PSA) measurement between benign and malignant tumor cells is currently under controversial discussion, the best and the most promising epigenetic marker for prostate cancer detection is the hypermethylation of GSTP1.